BLOG: GSTA1*B polymorphism may be prognostic for treosulfan-based HCT in beta-thalassemia
Blogs | | A treosulfan-based reduced-toxicity conditioning regimen has significantly improved hematopoietic cell transplantation outcomes for patients with high-risk thalassemia major and hematologic malignancies.However, complications related to regimen-related toxicities, mixed chimerism and graft rejection limit its success.
Source: healio.com